Abstract The SAGE has issued 3 interim statements on the below COVID-19 related issues: Interim statement on heterologous priming for COVID-19 vaccines Interim statement on dose-sparing strategies for COVID-19 vaccines (fractionated vaccine doses) Interim statement on COVID-19 vaccine booster doses SAGE
